An NIH Director's Wednesday Afternoon Lecture Series Event
"Past and Future Therapy of Hepatitis C"
Speaker: Dr. Jay H. Hoofnagle
Wednesday, Nov.12, 2014
3 pm - 4 pm
Clinical Center, Building 10
National Institutes of Health
Jay H. Hoofnagle, MD, presented the 17th annual Astute Clinician Lecture as part of the Wednesday Afternoon Lecture Series on Nov. 12, 2014.
Dr. Hoofnagle, Director, Liver Disease Research Branch, presented the Annual Astute Clinician Lecture on Nov. 12, 2014. His lecture, "Past and Future Therapy of Hepatitis C" can be viewed on NIH Videocast.
Visit the Wednesday Afternoon Lecture Series website.
The Astute Clinician Lecture Series
The Astute Clinician Lecture was established through a gift from the late Dr. Robert W. Miller and his wife, Haruko. It honors a US clinician-scientist who has observed an unusual clinical occurrence, and by investigating it, has opened an important new avenue of research.
Continuing Medical Education (CME) activities offered by NIH are jointly sponsored in partnership with The Johns Hopkins University School of Medicine Office of CME.
The WALS is intended for advanced students and practitioners in biomedical fields, healthcare professionals, and doctoral-level scientists who seek to update and broaden their understanding of contemporary biomedical research and the environment in which it is conducted.
Activity Description: The Wednesday Afternoon Lecture Series provides a mechanism to stay abreast of state-of-the-art biomedical and health research.
Intended Audience: All physicians, allied health professionals and non-clinical scientists, as well as the general public, are invited to attend the Wednesday Afternoon Lecture Series.
Objectives: After attending the activity, participants will be able to: (1) define options, alternatives, and new practices that will guide the conduct of research; (2) evaluate practical information presented about laboratory, clinical, and population-based research principles based on state-of-the-art scientific discovery and achievements; and (3) analyze information and opportunities to increase and improve collaboration among investigators and move scientific frontiers forward, especially to bridge areas of laboratory, translational, and clinical research.
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and the National Institutes of Health. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this live activity for a maximum of 39 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Speaker and Provider Disclosure: It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.